Kenvue Inc (J4D) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,21%	1 091,51	−2,30	−0,21%	—	1 093,81	1 096,52	1 100,22	1 091,51	—	—
SIXC Communications SIXC Communications	SIXC +0,22%	610,11	+1,34	+0,22%	—	608,77	608,77	612,97	608,77	—	—
SIXE Energy SIXE Energy	SIXE −1,34%	1 237,98	−16,83	−1,34%	—	1 254,81	1 253,01	1 253,87	1 226,33	—	—
SIXI Industrials SIXI Industrials	SIXI −0,93%	1 744,71	−16,40	−0,93%	—	1 761,11	1 764,27	1 766,88	1 744,71	—	—
SIXM Financials SIXM Financials	SIXM −0,37%	640,18	−2,40	−0,37%	—	642,58	644,87	648,48	640,18	—	—
SIXR Staples SIXR Staples	SIXR −0,18%	849,58	−1,55	−0,18%	—	851,13	855,66	858,75	845,56	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,23%	217,48	−0,50	−0,23%	—	217,98	217,98	218,65	216,88	—	—
SIXT Technology SIXT Technology	SIXT +1,52%	3 260,69	+48,86	+1,52%	—	3 211,83	3 227,21	3 268,38	3 226,55	—	—
SIXU Utilities SIXU Utilities	SIXU −0,69%	942,45	−6,53	−0,69%	—	948,98	948,58	957,83	941,97	—	—
SIXV Health care SIXV Health care	SIXV −0,52%	1 466,80	−7,72	−0,52%	—	1 474,52	1 479,03	1 481,04	1 466,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,22%	2 397,50	+5,38	+0,22%	—	2 392,12	2 396,95	2 421,22	2 382,32	—	—

J4D:FRA

Kenvue Inc

14,60 €

+0,69%

(+0,100) 1 D

4. mai, 15:25:01 GMT+2 · EUR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for J4D …

Åpne

14,58 €

Høy

14,60 €

Lav

14,58 €

Markedsverdi

33,10 mrd.

Snittvolum

98,00

Volum

0,00

52 u høy

22,20 €

52 u lav

11,83 €

Antall ansatte

22k

Nyhetssaker

Fra kilder på nettet

MarketBeat

for 3 døgn siden

Kenvue Inc. $KVUE Shares Purchased by Wealthfront Advisers LLC

WSJ

for 2 uker siden

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

Profil

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia

Om Kenvue Inc

Administrerende direktør-

Ansatte21,9k

Grunnlagt23. feb. 2022

HovedkontorSummit, New Jersey, USA

SektorPersonal care products

Nettstedkenvue.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	3,74 mrd.	3,84 mrd.	3,76 mrd.	3,78 mrd.
Varekostnad	1,57 mrd.	1,57 mrd.	1,53 mrd.	1,63 mrd.
Direkte driftskostnader	1,57 mrd.	1,57 mrd.	1,53 mrd.	1,63 mrd.
Utgifter til forskning og utvikling	-	-	-	-
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	1,54 mrd.	1,50 mrd.	1,51 mrd.	1,51 mrd.
Driftskostnader	1,55 mrd.	1,51 mrd.	1,51 mrd.	1,48 mrd.
Totale driftskostnader	3,12 mrd.	3,08 mrd.	3,04 mrd.	3,11 mrd.
Driftsinntekter	625,00 mill.	760,00 mill.	726,00 mill.	674,00 mill.
Andre ikke-operasjonelle inntekter	-	1,00 mill.	10,00 mill.	7,00 mill.
EBT inkludert uvanlige elementer	458,00 mill.	588,00 mill.	526,00 mill.	427,00 mill.
EBT uten uvanlige elementer	525,00 mill.	656,00 mill.	623,00 mill.	574,00 mill.
Kostnad for inntektsskatt	136,00 mill.	168,00 mill.	128,00 mill.	97,00 mill.
Faktisk avgiftssats	29,69 %	28,57 %	24,33 %	22,72 %
Andre driftskostnader	13,00 mill.	5,00 mill.	1,00 mill.	−30,00 mill.
Nettoinntekt	322,00 mill.	420,00 mill.	398,00 mill.	330,00 mill.
Netto fortjenestemargin	8,61 %	10,94 %	10,57 %	8,73 %
Resultat per aksje	0,24	0,29	0,28	0,27
Rente- og investeringsinntekter	13,00 mill.	13,00 mill.	14,00 mill.	11,00 mill.
Rentekostnader	−107,00 mill.	−107,00 mill.	−107,00 mill.	−109,00 mill.
Netto rentekostnader	−94,00 mill.	−94,00 mill.	−93,00 mill.	−98,00 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	761,00 mill.	902,00 mill.	867,00 mill.	713,00 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning